Trial Profile
Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous Infusion to Patients With Non-Dialysis Dependent Chronic Kidney Disease
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Ferric derisomaltose (Primary)
- Indications Iron deficiency anaemia
- Focus Pharmacokinetics
- Sponsors Pharmacosmos
- 13 Jun 2014 New trial record